Kuehne + Nagel wins contract with Organon Ireland
Organon’s vision, to continuously develop and sustain its position as one of the leading pharmaceutical companies in each of its core therapeutic fields, is driven by a combination of independent growth and business partnerships. The company has been building on its success with a growth strategy which included forming a partnership with a logistics service provider which has global coverage and the ability to offer a one-stop-shop solution through a quality and value-add focused relationship.
Kuehne + Nagel was chosen due to the sustainable benefits it offers, including full visibility for all shipments globally, efficient transport solutions with many additional service options, combined with a partnership approach focused on delivering a value-add service in a structured and sustainable manner.
Under the scope of the contract Kuehne + Nagel will manage the inbound transportation by road, sea and air to the Organon facility in Swords and outbound transportation by road, sea and air including temperature controlled/cold chain services to Organon’s global customer base.
Organon discovers, develops, manufactures and markets a wide range of high quality original prescription medicines including products in the fields of gynecology, mental health, anesthesia, and fertility – products that contribute to the health of people and their quality of life.
In Ireland, Organon has located one of its two global manufacturing sites on a 31 acre site near Swords Village, Co Dublin, employing approximately 600 people. The site uses the latest manufacturing technology and processes to make a range of products which are packaged for over 50 countries worldwide.
Gerry Coughlan, Logistics Director for Organon Ireland, comments “In order to successfully compete in a global environment it is important for us to work in a partnership with suppliers who can deliver a value-add service. This new collaboration with Kuehne + Nagel will allow us to further enhance our already high level of service to our customers.”
Marcus Bennett, Managing Director of Kuehne + Nagel Ireland, adds “Working with and developing a business partnership with Organon has been a pleasure for our team, as both organisations have a similar vision towards our respective customer bases, in that we both strive to deliver quality and value-add service offerings.“
Organon – with shared head offices in Roseland, NJ, USA and Oss, The Netherlands – creates, manufactures and markets prescription medicines that improve the health and quality of human life. Through a combination of independent growth and business partnerships, Organon strives to remain or become one of the leading pharmaceutical companies in each of its core therapeutic fields: gynecology, fertility, neuroscience and anesthesia. Organon products are sold in over 100 countries, of which more than 60 have an Organon subsidiary. Organon is the human health care business unit of Akzo Nobel. For further information, please visit www.organon.com